Total Payments
$5,111
2024 Payments
$1,233
Companies
19
Transactions
66
Medicare Patients
827
Medicare Billing
$40,493
Payment Breakdown by Category
Food & Beverage$4,773 (93.4%)
Other$300.00 (5.9%)
Education$37.65 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,773 | 64 | 93.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $300.00 | 1 | 5.9% |
| Education | $37.65 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| CooperVision Inc. | $1,583 | 17 | $0 (2021) |
| Bausch & Lomb Americas Inc. | $1,467 | 22 | $0 (2024) |
| Bausch & Lomb, a division of Bausch Health US, LLC | $417.94 | 6 | $0 (2021) |
| OPTOVUE, INC. | $309.74 | 3 | $0 (2018) |
| Alcon Vision LLC | $161.38 | 3 | $0 (2020) |
| Glaukos Corporation | $138.35 | 1 | $0 (2024) |
| Horizon Therapeutics plc | $125.87 | 2 | $0 (2022) |
| Tarsus Pharmaceuticals, Inc. | $123.91 | 1 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $119.85 | 1 | $0 (2021) |
| ABBVIE INC. | $114.95 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,233 | 17 | Bausch & Lomb Americas Inc. ($794.90) |
| 2023 | $481.57 | 8 | Bausch & Lomb Americas Inc. ($418.01) |
| 2022 | $495.37 | 5 | Bausch & Lomb Americas Inc. ($254.55) |
| 2021 | $261.85 | 3 | Bausch & Lomb, a division of Bausch Health US, LLC ($125.00) |
| 2020 | $486.67 | 6 | Bausch & Lomb, a division of Bausch Health US, LLC ($250.00) |
| 2019 | $619.74 | 10 | CooperVision Inc. ($385.58) |
| 2018 | $933.83 | 10 | CooperVision Inc. ($566.56) |
| 2017 | $599.11 | 7 | CooperVision Inc. ($423.03) |
All Payment Transactions
66 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $121.60 | General |
| Category: Ophthalmology | ||||||
| 10/15/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Ophthalmology | ||||||
| 09/25/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $98.89 | General |
| Category: Ophthalmology | ||||||
| 09/16/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $6.86 | General |
| Category: Ophthalmology | ||||||
| 07/22/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $101.53 | General |
| Category: Ophthalmology | ||||||
| 07/22/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $8.58 | General |
| Category: Ophthalmology | ||||||
| 06/28/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $123.91 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/04/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $98.36 | General |
| Category: Ophthalmology | ||||||
| 06/03/2024 | Apellis Pharmaceuticals, Inc. | Syfovre (Drug) | Food and Beverage | Cash or cash equivalent | $103.40 | General |
| Category: Ophthalmology | ||||||
| 05/20/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Ophthalmology | ||||||
| 05/14/2024 | LKC Technologies, Inc. | — | Food and Beverage | In-kind items and services | $71.99 | General |
| 04/16/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $69.32 | General |
| Category: Ophthalmology | ||||||
| 03/11/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $116.51 | General |
| Category: Ophthalmology | ||||||
| 02/06/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $23.00 | General |
| Category: Ophthalmology | ||||||
| 01/24/2024 | Glaukos Corporation | CE-marked KXLA system (Device) | Food and Beverage | Cash or cash equivalent | $138.35 | General |
| Category: Corneal Health | ||||||
| 01/03/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $102.92 | General |
| Category: Ophthalmology | ||||||
| 01/03/2024 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $8.86 | General |
| Category: Ophthalmology | ||||||
| 12/14/2023 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: Ophthalmology | ||||||
| 10/16/2023 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $108.31 | General |
| Category: Ophthalmology | ||||||
| 10/02/2023 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $22.73 | General |
| Category: Ophthalmology | ||||||
| 09/28/2023 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $63.56 | General |
| Category: DRY EYE | ||||||
| 09/26/2023 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Ophthalmology | ||||||
| 08/29/2023 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $107.55 | General |
| Category: Ophthalmology | ||||||
| 07/17/2023 | Bausch & Lomb Americas Inc. | INFUSE (Device) | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Ophthalmology | ||||||
| 03/15/2023 | Bausch & Lomb Americas Inc. | ULTRA MULTIFOCAL TORIC (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 203 | 229 | $19,433 | $9,699 |
| 2022 | 6 | 228 | 248 | $21,329 | $10,631 |
| 2021 | 6 | 222 | 245 | $21,004 | $11,675 |
| 2020 | 5 | 174 | 189 | $16,531 | $8,488 |
Total Patients
827
Total Services
911
Medicare Billing
$40,493
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 53 | 65 | $5,850 | $3,693 | 63.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 48 | $5,520 | $3,394 | 61.5% |
| 92134 | Imaging of retina | Office | 2023 | 50 | 52 | $3,640 | $1,064 | 29.2% |
| 92250 | Photography of the retina | Office | 2023 | 27 | 28 | $2,128 | $678.38 | 31.9% |
| 92133 | Imaging of optic nerve | Office | 2023 | 19 | 21 | $1,470 | $455.18 | 31.0% |
| 92082 | Exam of visual field with intermediate testing | Office | 2023 | 13 | 15 | $825.00 | $414.08 | 50.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 69 | $7,935 | $4,794 | 60.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 39 | 45 | $4,050 | $2,525 | 62.3% |
| 92134 | Imaging of retina | Office | 2022 | 59 | 60 | $4,200 | $1,501 | 35.7% |
| 92250 | Photography of the retina | Office | 2022 | 38 | 39 | $2,964 | $921.28 | 31.1% |
| 92082 | Exam of visual field with intermediate testing | Office | 2022 | 16 | 18 | $990.00 | $531.00 | 53.6% |
| 92133 | Imaging of optic nerve | Office | 2022 | 16 | 17 | $1,190 | $358.69 | 30.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 54 | 66 | $7,590 | $5,306 | 69.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 41 | 49 | $4,410 | $2,923 | 66.3% |
| 92134 | Diagnostic imaging of retina | Office | 2021 | 56 | 58 | $4,060 | $1,466 | 36.1% |
| 92250 | Photography of the retina | Office | 2021 | 35 | 35 | $2,654 | $935.58 | 35.3% |
| 92082 | Measurement of field of vision during daylight conditions, intermediate examination | Office | 2021 | 19 | 20 | $1,100 | $631.51 | 57.4% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 17 | 17 | $1,190 | $412.06 | 34.6% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 55 | 60 | $6,900 | $4,103 | 59.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 27 | 32 | $2,880 | $1,512 | 52.5% |
| 92134 | Diagnostic imaging of retina | Office | 2020 | 41 | 44 | $3,080 | $1,221 | 39.7% |
| 92250 | Photography of the retina | Office | 2020 | 36 | 36 | $2,736 | $1,084 | 39.6% |
| 92082 | Measurement of field of vision during daylight conditions | Office | 2020 | 15 | 17 | $935.00 | $568.54 | 60.8% |
About John Zelazowski
John Zelazowski is a Optometrist healthcare provider based in Cheswick, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/09/2005. The National Provider Identifier (NPI) number assigned to this provider is 1497736227.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Zelazowski has received a total of $5,111 in payments from pharmaceutical and medical device companies, with $1,233 received in 2024. These payments were reported across 66 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($4,773).
As a Medicare-enrolled provider, Zelazowski has provided services to 827 Medicare beneficiaries, totaling 911 services with total Medicare billing of $40,493. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Optometrist
- Location Cheswick, PA
- Active Since 11/09/2005
- Last Updated 03/07/2023
- Taxonomy Code 152W00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1497736227
Products in Payments
- INFUSE (Device) $1,338
- Clariti Contact Lens (Device) $869.95
- XR (Device) $309.74
- Non-Product Brand Specific (Device) $300.00
- ULTRA MULTIFOCAL TORIC (Device) $254.55
- BIOTRUE (Device) $250.00
- Biofinity Contact Lens (Device) $229.90
- ULTRA (Device) $154.66
- CE-marked KXLA system (Device) $138.35
- TEPEZZA (Drug) $125.87
- XDEMVY (Drug) $123.91
- EYLEA (Biological) $119.85
- VUITY (Drug) $114.95
- Syfovre (Drug) $103.40
- DAILIES (Device) $98.58
- Proclear Contact Lens (Device) $93.86
- MyDay Contact Lens (Device) $89.22
- TearCare (Device) $64.65
- TYRVAYA (Drug) $63.56
- ILUX (Device) $42.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.